Related Experiment Videos
Consumerism for neurobiological disorders. An assessment
1Yale University School of Medicine, USA.
International Journal of Technology Assessment in Health Care
|October 1, 1996
Summary
Consumerism in mental health care faces barriers due to limited understanding and data. Advocates must leverage neuroscientific evidence to demand evidence-based, equitable treatment programs for neurobiological disorders.
Area of Science:
- Health Care Consumerism
- Neuroscience
- Mental Health Care Policy
Background:
- Consumerism is increasing in US healthcare but faces resistance.
- It is particularly challenging in mental health care compared to other medical fields.
- Limited public understanding of neurobiological disorders hinders progress.
Purpose of the Study:
- To explore the challenges and opportunities for consumerism in mental health care.
- To identify strategies for advocates to promote equitable and effective treatment.
- To emphasize the role of neuroscientific advancements in driving change.
Main Methods:
- Analysis of the current landscape of mental health care consumerism.
- Review of barriers including poor treatment definitions and lack of outcome data.
- Examination of the potential of neuroscientific evidence to support consumer advocacy.
Main Results:
- Consumerism in mental health is inhibited by medical community forces and public perception.
- Lack of robust outcome data, especially from long-term studies, impedes progress.
- Neuroscientific evidence highlights the physical basis of mental illness, offering a path forward.
Conclusions:
- Advocates must align with the neuroscientific revolution to advance consumerism.
- Demand for treatment programs based on evidence of neurobiological disorders is crucial.
- Equitable and effective mental health care requires integrating scientific understanding with patient advocacy.